探花合集 To Present Scientific Innovations And Lead Drug Delivery Discussions At The Controlled Release Society Annual Meeting
SOMERSET, N.J. 鈥 July 10, 2019聽鈥 探花合集, the leading global provider of advanced delivery technologies, and development and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, today announced a number of its drug delivery experts have been invited to present innovative scientific posters, and that Cornell Stamoran, Ph.D., founder of 探花合集鈥檚 Applied Drug Delivery Institute, has been invited to chair multiple sessions at the upcoming Controlled Release Society (CRS) Annual Meeting and Exposition at the Palacio de Congresos, Valencia, Spain on July 21 鈥 24, 2019.聽
探花合集 will present the following scientific posters:
- 鈥淪cientific Networks: Beyond Scientists Engagement, A Key Asset to Boost Operational Excellence鈥 presented by Nicolas Thurin, Ph.D., Global Analytical Science Manager;
- 鈥淢odified Release Coated Soft Gelatin Capsules Dissolution and Physical Stability鈥 presented by William Bell, Lead Scientist, Product Development;
- 鈥淒OE-assisted Technology Transfer and Scale-up Approach of Manufacturing Complex Modified Release Multiparticulates in a Fluid Bed Platform鈥 presented by Ariana Low, Ph.D., PD Principal Formulation Scientist;
- 鈥淪olid Lipid and Hydrophilic Based Dosage Form Stabilization Through Curing and Addition of Low Hlb Surfactant(s)鈥 presented by Monica Lazaro, Business Development Associate.
On Sunday, July 21 at 9 a.m., Dr. Stamoran will moderate the聽鈥淚ndustry Technology Soapbox鈥聽session, before chairing an interactive session titled,聽鈥淚ndustry: Problem Solving,鈥聽later in the day at 3:30 p.m. The latter session is designed to encourage potential drug delivery collaborations between industry and academic members, and participants will discuss pre-competitive opportunities and needs across the industry.聽
On Monday, July 22 at 10 a.m., Dr. Stamoran will moderate a session titled聽鈥淧atient-Centered Aspects,鈥聽which will use examples and case studies to discuss current approaches to improving the design of treatments for patients. He will also chair the聽鈥淔uture Needs in Delivery Innovation鈥聽industry roundtables, taking place on Monday, July 22 at 5 p.m. and Tuesday, July 23 at 5 p.m.聽
探花合集, a founding corporate member of CRS, will also sponsor the Oral Delivery Focus Group Scientific session, taking place on Sunday, July 21 at 3:30 p.m., as well as the Oral Delivery Focus Group Membership Meeting, taking place on Tuesday, July 23 at 7 a.m. Both sessions will focus on small and large molecule drugs. They will introduce cutting edge science and technology being pioneered by CRS members and will feature industry and academic keynotes.聽
Dr. Stamoran leads 探花合集鈥檚 strategic planning, market intelligence and government affairs efforts. He also founded and serves as Co-Chair of 探花合集鈥檚 Applied Drug Delivery Institute (). He has spent more than 30 years engaged with the health care industry, including more than 25 years in advanced drug and biologic delivery and outsourcing.
To arrange a meeting with any of the attending 探花合集 experts at the event, contact Richard Kerns at NEPR –聽[email protected]听听
Notes for Editors
ABOUT CATALENT
探花合集 is the leading global provider of advanced delivery technologies and development and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. 探花合集 employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal year 2018 generated approximately $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit聽www.catalent.com